Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05555069 · ClinicalTrials.gov registry record · NA

The Impact of Menthol Flavoring on Switching in Adult Menthol Smokers

A NA study of Smoking Reduction, sponsored by Nikki Nollen, PhD, MA.

Recruiting
Registry status
NA
Development phase
800
Enrollment target
1
Study location

NCT05555069 is a NA study of Smoking Reduction that is actively recruiting participants, run by Nikki Nollen, PhD, MA. The registered enrollment target is 800 participants, above the 208-participant average among 10 other Smoking Reduction trials with a reported enrollment target (285% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05555069, a NA study of Smoking Reduction, is actively recruiting participants, sponsored by Nikki Nollen, PhD, MA.

RECRUITING
Registry status
NA
Development phase
800 participants
Enrollment target
1
Study location

Study Summary

This study will compare the efficacy of menthol-flavored versus tobacco-flavored 4th generation nicotine salt-based pod-system e-cigarettes in facilitating a switch from combustible cigarettes to e-cigarettes in adult menthol smokers.

Conditions Studied

Interventions

  • OTHER Menthol-flavored electronic cigarette
  • OTHER Tobacco-flavored electronic cigarette

Study Locations (1)

Missouri

  • University of Kansas Medical Center - Kansas City

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2022-11-08
Est. Completion 2027-03-31
Phase NA

Sponsor

Nikki Nollen, PhD, MA

3 total trials

What the Registry Record Tells You About NCT05555069

The ClinicalTrials.gov registry entry for NCT05555069 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 208-participant average among 10 other Smoking Reduction trials with a reported enrollment target (285% higher). The listed sponsor is Nikki Nollen, PhD, MA, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Smoking Reduction appearing as the primary indexed condition, and to 2 interventions - of which Menthol-flavored electronic cigarette is the first listed.

NCT05555069 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT05555069 about?

NCT05555069 is a clinical study titled "The Impact of Menthol Flavoring on Switching in Adult Menthol Smokers". This study will compare the efficacy of menthol-flavored versus tobacco-flavored 4th generation nicotine salt-based pod-system e-cigarettes in facilitating a switch from combustible cigarettes to e-cigarettes in adult menthol smokers.

What is the current status of trial NCT05555069?

This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2022-11-08. Estimated completion is 2027-03-31.

What conditions does trial NCT05555069 study?

This clinical trial studies the following conditions: Smoking Reduction.

What interventions are being tested in trial NCT05555069?

The interventions under investigation include: Menthol-flavored electronic cigarette (OTHER), Tobacco-flavored electronic cigarette (OTHER).

Who is sponsoring clinical trial NCT05555069?

This trial is sponsored by Nikki Nollen, PhD, MA, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05555069 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Reduction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.